{"data":{"id":4942,"citation":"Wiergowska G, Stasi\u0142owicz A, Miklaszewski A, Lewandowska K, Cielecka-Piontek J.: Structural Polymorphism of Sorafenib Tosylate as a Key Factor in Its Solubility Differentiation.. Pharmaceutics, Volume 13 (3), 384, 2021","title":"Structural Polymorphism of Sorafenib Tosylate as a Key Factor in Its Solubility Differentiation.","doi":"10.3390\/pharmaceutics13030384","doi_url":"https:\/\/doi.org\/10.3390\/pharmaceutics13030384","pmid":"33805754","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/33805754\/","year":2021,"journal":"Pharmaceutics","volume":"13","issue":"3","page":"384","authors":[{"first_name":"Gabriela","last_name":"Wiergowska","full_name":"Wiergowska G"},{"first_name":"Anna","last_name":"Stasi\u0142owicz","full_name":"Stasi\u0142owicz A"},{"first_name":"Andrzej","last_name":"Miklaszewski","full_name":"Miklaszewski A"},{"first_name":"Kornelia","last_name":"Lewandowska","full_name":"Lewandowska K"},{"first_name":"Judyta","last_name":"Cielecka-Piontek","full_name":"Cielecka-Piontek J"}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/4942","landing_page":"https:\/\/molmedb.upol.cz\/publication\/4942","created_at":"2026-07-09T23:42:23.000000Z","updated_at":"2026-07-09T23:42:23.000000Z"}}